The article highlights the urgent review requested by Brazil's Ministry of Agriculture for Spidoxamat, a new active ingredient in Bayer's insecticide Plenexos, due to the threat of citrus Huanglongbing disease. This disease, spread by the Asian citrus psyllid, poses a significant risk to the citrus industry. Plenexos, set for a 2026 launch, targets these pests while protecting beneficial insects and pollinators by inhibiting acetyl-CoA carboxylase. Having passed health safety checks by Anvisa, it now awaits environmental approval from Ibama.